S. P. Sidorenko

发表

CD150-mediated Akt signalling pathway in normal and malignant B cells.

E. Kashuba, B. Snopok, M. Yurchenko, 2011, Experimental oncology.

Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.

K. V. Korneev, Anna V Klepikova, I. Kulakovskiy, 2016, Biochimica et biophysica acta.

CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis.

L. M. Shlapatska, S. P. Sidorenko, E. Clark, 1999, Journal of immunology.

The dual-function CD150 receptor subfamily: the viral attraction

S. P. Sidorenko, E. Clark, 2003, Nature Immunology.

The role of CD150-SH2D1A association in CD150 signaling in Hodgkin's lymphoma cell lines.

E. Kashuba, M. Yurchenko, S. P. Sidorenko, 2005, Experimental oncology.

Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex.

C. Disteche, S. Edelhoff, A. Weiss, 1994, The Journal of biological chemistry.

Regulation of Signalling Through B‐Lymphocyte Antigen Receptors by Cell‐Cell Interaction Molecules

S. P. Sidorenko, C. Law, K. Otipoby, 1996, Immunological reviews.

Fas-mediated apoptosis in human prostatic carcinoma cell lines.

M. Cohen, G. Bishop, S. P. Sidorenko, 1997, Cancer research.

CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A1

K. Nichols, S. P. Sidorenko, E. Clark, 2001, The Journal of Immunology.

Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. I. Cell surface phenotype and functional studies.

S. P. Sidorenko, L. Shlapatska, I. Gordiienko, 2014, Experimental oncology.

Measles virus hemagglutinin triggers intracellular signaling in CD150-expressing dendritic cells and inhibits immune response

S. P. Sidorenko, T. Seya, B. Horvat, 2015, Cellular and Molecular Immunology.

Immunohistochemical studies of protein kinase D (PKD) 2 expression in malignant human lymphomas.

O. Yurchenko, S. P. Sidorenko, J. Van Lint, 2006, Experimental oncology.

Protein SH 2 D 1 A Phosphatase Is Regulated by the Adaptor SH 2-Containing Protein Tyrosine SH 2-Containing Inositol Phosphatase or the CD 150 Association with Either the Nichols

K. Nichols, S. P. Sidorenko, E. Clark, 2001 .

Protein kinase C mu (PKC mu) associates with the B cell antigen receptor complex and regulates lymphocyte signaling.

T. Kurosaki, S. P. Sidorenko, E. Clark, 1996, Immunity.

Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.

S. P. Sidorenko, E. Clark, 1993, Journal of immunology.

Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. II. receptor-mediated Akt/PKB and ERK1/2 activation and transcription factors expression profile.

S. P. Sidorenko, L. Shlapatska, I. Gordiienko, 2014, Experimental oncology.

Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells

S. P. Sidorenko, E. Clark, L. Pinchuk, 1996, Journal of medical primatology.

Human spleen tyrosine kinase p72Syk associates with the Src-family kinase p53/56Lyn and a 120-kDa phosphoprotein.

S. P. Sidorenko, E. Clark, C. Law, 1995, Proceedings of the National Academy of Sciences of the United States of America.

The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells.

K. Nichols, O. Yurchenko, M. Yurchenko, 2004, Blood.

IMMUNOHISTOCHEMICAL STUDIES OF CD 150 EXPRESSION IN SOME HUMAN TUMORS

O. Yurchenko, M. Yurchenko, S. P. Sidorenko, 2004 .

The multilevel regulation of CD95 signaling outcome.

M. Yurchenko, L. M. Shlapatska, S. P. Sidorenko, 2012, Experimental oncology.

Phospholipase C-gamma1 interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk

S. P. Sidorenko, E. Clark, C. Law, 1996, Molecular and cellular biology.

CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation

Z. Zhao, Z. Zhao, E. Fischer, 1996, The Journal of experimental medicine.

The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling

S. P. Sidorenko, E. Clark, L. Shlapatska, 2017, PloS one.

Hodgkin's lymphoma: the role of cell surface receptors in regulation of tumor cell fate.

M. Yurchenko, S. P. Sidorenko, 2010, Experimental oncology.

Accessory molecules that influence signaling through B lymphocyte antigen receptors.

S. P. Sidorenko, I. Berberich, E. Clark, 1994, Advances in experimental medicine and biology.

FCRL6 receptor: expression and associated proteins.

Mariya Y Yurchenko, A. Zamoshnikova, S. P. Sidorenko, 2011, Immunology letters.

CD150 regulates JNK1/2 activation in normal and Hodgkin's lymphoma B cells

Mariya Y Yurchenko, S. P. Sidorenko, E. Clark, 2010, Immunology and cell biology.

Regulation of lymphocyte activation by the cell-surface molecule CD22.

S. P. Sidorenko, E. Clark, C. Law, 1994, Immunology today.

Dominant nature of the resistance to Fas- and tumor necrosis factor-alpha-mediated apoptosis in human prostatic carcinoma cell lines.

M. Cohen, A. Gudkov, G. Bishop, 1997, Cancer research.

SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?

S. P. Sidorenko, L. Shlapatska, I. Gordiienko, 2019, Clinical immunology.

CD45 ligation induces programmed cell death in T and B lymphocytes.

S. P. Sidorenko, E. Clark, S. Klaus, 1996, Journal of immunology.

The biological properties of HEK293T cell line transfected with mCD150 and nCD150 isoforms of CD150/SLAMF1 receptor

L. M. Shlapatska, S. P. Sidorenko, I. Gordiienko, 2020 .

Expression of CD150 in Tumors of the Central Nervous System: Identification of a Novel Isoform

Mariya Y Yurchenko, S. P. Sidorenko, A. Najakshin, 2015, PloS one.

Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.

O. Yurchenko, S. P. Sidorenko, A. G. Berdova, 1992, Neoplasma.